DayOnBay.ca is a student owned website targeted towards Canadian undergraduate business students interested in pursuing a career in finance. DayOnBay.ca strives to be a one-stop shop for Canadian business students who wish to learn more about careers such as Investment Banking, Sales & Trading, Private Equity, and other professions in finance. DayOnBay.ca has three distinct yet complementary content areas: current business news, careers in finance content, and news regarding student-run finance initiatives from across Canada.
I have been a dividend investor since my retirement in late 2003. I diversify by sector, domestic vs. international, and by cap size. I do not invest in stocks that don't pay dividends. I am risk averse and limit my investment in a single equity to 1% of my total assets or less. As a result of this 'rule', I have more than 100 equities in my portfolio.
Jason Wu is currently a portfolio manager at Optimization Asset Management LLC, a Long/Short hedge fund based in the U.S. Dr. Wu spent seven years as a quantitative strategist/portfolio manager at Perry Capital, an event driven hedge fund, where he managed quantitative strategies. Jason Wu also developed the risk management system and other quantitative price models for the company during a period when Perry’s asset under management grew from $1 billion to $8 billion. Prior to working at Perry Capital, Dr. Wu spent 5 years as a quantitative analyst at General Re, CDC Capital and Bankers Trust. Jason Wu has a Ph.D. in physics from Yale University and Bachelor of Science from Tsinghua University, Beijing, China.
Builds portfolios in USA and Sweden. I have a large portion "Buy and hold/monitor" stocks, but also some more playful growth stocks and mining. I have also participated in Employee Stock Purchase programs in which stocks are purchased at a discount (typically 15%) but try to make sure to adjust regularly (I sell at intervals) so that this part of my savings is not too large compared to my safer investments.
Ray 69 worked as a supplier of marketing goodies to the international pharma industry for his whole working life. Retired wealthy by taking candy from the dummies that populate the industry. Even now while they proclaim to know the big pharma model is bust they still haven't got the guts to make the radical jump into the new world